Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 25, 2003
Academy of Managed Care Pharmacy Format: relevance, rigor, regulation, and realism
Bernie J O'Brien
Health Affairs (Project Hope)
|
September 13, 2002
Economics and priority setting
Bernie J O'Brien
The Journal of Rheumatology. Supplement
|
January 10, 2004
Cost-effectiveness modeling in rheumatology: toward principles of good practice
Ron Goeree, Bernie J O'Brien
Health Economics
|
February 3, 2005
Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget
Gregory S Zaric, Bernie J O'brien
Pharmacoeconomics
|
August 31, 2002
Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death
Marian A Spath, Bernie J O'Brien
Journal of Cardiovascular Electrophysiology
|
September 3, 2003
Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence
Larry D Lynd, Bernie J O'Brien
Journal of Clinical Epidemiology
|
October 16, 2004
Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis
Larry D Lynd, Bernie J O'brien
Community Genetics
|
October 16, 2003
Economic considerations for health insurance coverage of emerging genetic tests
Mita Giacomini, Fiona Miller, Bernie J O'Brien
Health Economics
|
May 6, 2004
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions
Elisabeth Fenwick, Bernie J O'Brien, Andrew Briggs
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Principles of good modeling practice in healthcare cost-effectiveness studies
Ron Goeree, Bernie J O'Brien, Gord Blackhouse
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 25, 2003
Academy of Managed Care Pharmacy Format: relevance, rigor, regulation, and realism
Bernie J O'Brien
Health Affairs (Project Hope)
|
September 13, 2002
Economics and priority setting
Bernie J O'Brien
The Journal of Rheumatology. Supplement
|
January 10, 2004
Cost-effectiveness modeling in rheumatology: toward principles of good practice
Ron Goeree, Bernie J O'Brien
Health Economics
|
February 3, 2005
Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget
Gregory S Zaric, Bernie J O'brien
Pharmacoeconomics
|
August 31, 2002
Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death
Marian A Spath, Bernie J O'Brien
Journal of Cardiovascular Electrophysiology
|
September 3, 2003
Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence
Larry D Lynd, Bernie J O'Brien
Journal of Clinical Epidemiology
|
October 16, 2004
Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis
Larry D Lynd, Bernie J O'brien
Community Genetics
|
October 16, 2003
Economic considerations for health insurance coverage of emerging genetic tests
Mita Giacomini, Fiona Miller, Bernie J O'Brien
Health Economics
|
May 6, 2004
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions
Elisabeth Fenwick, Bernie J O'Brien, Andrew Briggs
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Principles of good modeling practice in healthcare cost-effectiveness studies
Ron Goeree, Bernie J O'Brien, Gord Blackhouse
Page
of 5